Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
Gut Liver
.
2017 Jan 15;11(1):3-4.
doi: 10.5009/gnl16574.
Author
Chang Soo Eun
1
Affiliation
1
Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea.
PMID:
28053295
PMCID:
PMC5221852
DOI:
10.5009/gnl16574
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibodies, Monoclonal
Drug Monitoring*
Humans
Inflammatory Bowel Diseases
Infliximab
Tumor Necrosis Factor-alpha*
Substances
Antibodies, Monoclonal
Tumor Necrosis Factor-alpha
Infliximab